APC/Cyanine7 anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_APCCy7_072210
C57BL/6 bone marrow cells stained with 1A8 APC/Cyanine7
  • 1A8_APCCy7_072210
    C57BL/6 bone marrow cells stained with 1A8 APC/Cyanine7
Compare all formats See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
127623 25 µg 80€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127624 100 µg 243€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Däbritz J, et al. 2016. Sci Rep. 6:20584. PubMed
  2. Zaman R, et al. 2021. Immunity. :. PubMed
  3. Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed
  4. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  5. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  6. Regev O, et al. 2022. Front Immunol. 13:849701. PubMed
  7. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  8. Deng J, et al. 2021. JCI Insight. 6:146133. PubMed
  9. Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed
  10. Kim EH, et al. 2020. Elife. 9:00. PubMed
  11. Hilliard K, et al. 2015. Infect Immun . 83: 4015 - 4027. PubMed
  12. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  13. Frank AC, et al. 2021. Theranostics. 11:7570. PubMed
  14. Weigert A, et al. 2022. Nat Commun. 13:6078. PubMed
  15. Price P, et al. 2014. J Virol. 88:10840. PubMed
  16. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  17. Minutti CM, et al. 2019. Immunity. 50:645. PubMed
  18. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  19. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
  20. Huard A, et al. 2021. J Immunol. 206:1058. PubMed
  21. Forte D, et al. 2020. Cell Metab. 32:829. PubMed
  22. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  23. Cai B, et al. 2021. Mol Cancer. 20:165. PubMed
  24. Linnerbauer M, et al. 2022. Front Immunol. 12:800128. PubMed
  25. Bresque M, et al. 2022. J Biol Chem. :101711. PubMed
  26. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  27. Han Y et al. 2019. Cell reports. 27(3):835-846 . PubMed
  28. Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed
  29. Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed
  30. Currier MA, et al. 2017. Oncotarget. 8:17412. PubMed
  31. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  32. Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed
  33. Kovács B, et al. 2020. Front Immunol. 2.508333333. PubMed
  34. Anderson MC, et al. 2018. Cell Chem Biol. 25:483. PubMed
  35. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  36. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  37. Yoshida K, et al. 2022. Sci Rep. 12:17276. PubMed
  38. Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed
  39. Woods T, et al. 2016. J Virol. 90: 2783 - 2793. PubMed
  40. Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed
  41. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  42. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
  43. Zhang J, et al. 2015. Sci Rep. 5: 15553. PubMed
  44. Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
  45. Stutz MD, et al. 2021. Immunity. 54(8):1758-1771.e7. PubMed
  46. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  47. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  48. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  49. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  50. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  51. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  52. Saha S, et al. 2016. Nat Commun. 7:13096. PubMed
  53. Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed
  54. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  55. Wang SK, et al. 2021. JCI Insight. 6: . PubMed
  56. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  57. Wilson R, et al. 2016. Nat Commun. 7:13597. PubMed
  58. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  59. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  60. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  61. Andriessen EMMA, et al. 2021. EMBO Mol Med. 13:e11754. PubMed
  62. Wang YT, et al. 2020. Nat Microbiol. 0.397222222. PubMed
  63. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  64. Matthew B Buechler et al. 2019. Immunity. 51(1):119-130 . PubMed
  65. Buzzelli JN, et al. 2019. Am J Physiol Gastrointest Liver Physiol. 316:G251. PubMed
  66. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  67. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  68. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  69. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  70. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  71. Franklin DA, et al. 2020. JCI Insight. 5:. PubMed
  72. Fontana MF, et al. 2015. Parasite Immunol. 37: 470-478. PubMed
  73. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  74. Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed
  75. Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed
  76. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  77. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  78. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  79. Briukhovetska D, et al. 2020. Frontiers in Immunology. 1.428472222. PubMed
  80. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  81. Ni Y, et al. 2021. Theranostics. 11:9431. PubMed
  82. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  83. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  84. Jaitin DA et al. 2016. Cell. 167(7):1883-1896 . PubMed
  85. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
  86. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  87. Filtjens J, et al. 2021. Nat Commun. 12:2936. PubMed
  88. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  89. Zhang L, et al. 2020. Cell. 442:181. PubMed
  90. Lee MC, et al. 2017. J Immunol. 198:3565. PubMed
  91. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  92. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  93. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  94. Sen D, et al. 2016. PLoS One. 11:e0165064. PubMed
  95. Woods PS, et al. 2020. Am J Respir Cell Mol Biol. 62:243. PubMed
  96. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  97. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  98. Dodd RD, et al. 2017. Cancer Res. 77:4486. PubMed
  99. O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed
  100. Saleh R, et al. 2018. J Immunol. 201:2042. PubMed
  101. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  102. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  103. Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed
  104. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  105. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
RRID
AB_10645331 (BioLegend Cat. No. 127623)
AB_10640819 (BioLegend Cat. No. 127624)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F
Purified anti-mouse Ly-6G 1A8 FC, IHC-F, IHC
Biotin anti-mouse Ly-6G 1A8 FC, IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC, IHC-F
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC, IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC, IHC-F, SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC, IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC, Depletion, IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC, CyTOF®, WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Go To Top Version: 3    Revision Date: 01.06.2017

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Alexa Fluor® 594 anti-mouse Ly-6G

  • Purified anti-mouse Ly-6G

  • Biotin anti-mouse Ly-6G

  • FITC anti-mouse Ly-6G

  • PE anti-mouse Ly-6G

  • Alexa Fluor® 647 anti-mouse Ly-6G

  • Pacific Blue™ anti-mouse Ly-6G

  • APC anti-mouse Ly-6G

  • PerCP/Cyanine5.5 anti-mouse Ly-6G

  • PE/Cyanine7 anti-mouse Ly-6G

  • Alexa Fluor® 700 anti-mouse Ly-6G

  • APC/Cyanine7 anti-mouse Ly-6G

  • Alexa Fluor® 488 anti-mouse Ly-6G

  • Brilliant Violet 421™ anti-mouse Ly-6G

  • Brilliant Violet 570™ anti-mouse Ly-6G

  • Ultra-LEAF™ Purified anti-mouse Ly-6G

  • Brilliant Violet 510™ anti-mouse Ly-6G

  • Purified anti-mouse Ly-6G (Maxpar® Ready)

  • Brilliant Violet 650™ anti-mouse Ly-6G

  • Brilliant Violet 711™ anti-mouse Ly-6G

  • Brilliant Violet 605™ anti-mouse Ly-6G

  • Brilliant Violet 785™ anti-mouse Ly-6G

  • PE/Dazzle™ 594 anti-mouse Ly-6G

  • APC/Fire™ 750 anti-mouse Ly-6G

  • PerCP anti-mouse Ly-6G

  • TotalSeq™-A0015 anti-mouse Ly-6G

  • TotalSeq™-C0015 anti-mouse Ly-6G

  • TotalSeq™-B0015 anti-mouse Ly-6G

  • Spark Blue™ 550 anti-mouse Ly-6G

  • Spark NIR™ 685 anti-mouse Ly-6G

  • Spark YG™ 593 anti-mouse Ly-6G

  • APC/Fire™ 810 anti-mouse Ly-6G Antibody

  • PE/Cyanine5 anti-mouse Ly-6G

  • PE/Fire™ 810 anti-mouse Ly-6G Antibody

  • Spark UV™ 387 anti-mouse Ly-6G

  • PE/Fire™ 640 anti-mouse Ly-6G

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account